U.S. Immigration Policy

Business

Avery Dennison's Valuation in Focus as Smart Label Demand Offsets Market Volatility

Shares of materials and labeling giant Avery Dennison (NYSE: AVY) have shown resilience amid broader market swings, reigniting debate over its intrinsic value. With a significant gap between its current price and analyst targets, investors are weighing its growth in digital identification technologies against persistent sector headwinds.

Feb 2, 2026

Business

Glaukos Gains FDA Label Expansion for iDose TR, But Valuation Questions Loom

Glaukos Corporation's iDose TR glaucoma therapy receives a key FDA labeling update, permitting repeat administration. While the news bolsters the company's growth narrative, analysts are divided on whether its current stock price already reflects future potential amid rich valuation metrics.

Feb 2, 2026

Business

Lantronix Inks Defense AI Deal with Safe Pro, Fueling Growth Debate

Lantronix's new partnership to develop edge AI threat detection systems for drones has spotlighted the stock, but analysts are divided on whether its current valuation fully prices in the risks and opportunities of the nascent defense tech market.

Feb 2, 2026

Business

DoorDash Bets on Robots and Rural Seniors: A Dual-Pronged Strategy to Expand Its Reach

DoorDash is deploying autonomous delivery robots in the suburbs while advocating for legislation to improve food access for rural seniors, signaling a strategic push beyond its urban core into new markets and use cases.

Feb 2, 2026

Business

China's Pork Palate Shifts: Nostalgia and Premium Demand Drive Black Hog Revival

As China's pork industry grapples with overcapacity and falling prices, a growing appetite for premium, flavorful black pork among the middle class is offering a lifeline to farmers and reshaping market strategies.

Feb 2, 2026

World

Asahi Poll Predicts Landslide Victory for PM Takaichi's LDP in Upcoming Election

A new poll indicates Prime Minister Sanae Takaichi's ruling coalition is on track for a decisive win in next week's lower house election, potentially strengthening her mandate for expansive fiscal policies.

Feb 2, 2026

Business

Glaukos Gains FDA Nod for Repeat iDose TR Implant, Bolstering Its Long-Term Glaucoma Platform Strategy

The FDA's approval of a repeat treatment protocol for Glaukos's iDose TR implant transforms it from a one-time procedure into a potential chronic therapy platform, reshaping its commercial narrative and investor calculus in the competitive glaucoma market.

Feb 2, 2026

Business

First American Financial Maintains Dividend Amid Board Transition as Stock Holds Steady

First American Financial Corp. announces the retirement of director Martha Wyrsch while reaffirming its quarterly dividend, signaling stability in shareholder returns during a period of governance change. The company's stock performance and capital allocation strategy remain in focus for investors.

Feb 2, 2026

Business

Enterprise Products Pivots: From Growth Spree to Shareholder Returns

After years of heavy investment in organic growth, midstream giant Enterprise Products Partners signals a strategic shift, slashing future capital expenditures and ramping up buybacks to return more cash to investors.

Feb 2, 2026

World

From Sheds to Battlefields: How Europe's $920 Billion Defense Push Is Opening Doors for Startups

Faced with the realities of modern warfare in Ukraine, NATO is fast-tracking innovation, creating an unprecedented opportunity for agile tech founders to access a once-closed defense market.

Feb 2, 2026

Business

Davos Clash: Jamie Dimon's Heated Confrontation with Coinbase CEO Exposes Deep Rift Over Crypto's Future

A reported fiery exchange between JPMorgan's Jamie Dimon and Coinbase's Brian Armstrong at the World Economic Forum lays bare the intensifying battle between traditional finance and the crypto industry over regulation, deposits, and the future of money.

Feb 2, 2026

Business

Beyond the Hype: Marvell Technology Emerges as a Stealth AI Infrastructure Powerhouse

While investor attention fixates on flashier names, Marvell Technology's critical role in custom AI chips and data center infrastructure positions it for explosive growth, making its current valuation a potential opportunity.

Feb 2, 2026

Business

Starbucks Brews a Comeback: How AI and a Return to 'Third Place' Roots Aim to Revive the Coffee Giant

After years of sluggish sales and brand challenges, Starbucks is betting on a dual strategy: deploying AI to streamline operations while reinvesting in the in-store experience. CEO Brian Niccol outlines the plan he believes will restore growth and community connection.

Feb 2, 2026

Business

Chicago Capital Trims $12.5M Stake in Surgically Focused Robotic Firm PROCEPT BioRobotics

Amid a steep 60% annual share price decline, investment firm Chicago Capital has significantly reduced its position in PROCEPT BioRobotics, a developer of robotic systems for urological surgery, signaling a portfolio risk reassessment.

Feb 2, 2026

World

Labour's 'Prince of Darkness' Steps Down Amid Renewed Epstein Scandal

Peter Mandelson, a pivotal figure in the Blair-era Labour Party, has resigned his membership following fresh allegations concerning his ties to the late financier Jeffrey Epstein, marking another blow to the party's establishment.

Feb 2, 2026

World

India Weighs Social Media Ban for Under-16s as Lawmaker Cites Data Exploitation and Youth Safety

A key ally of Prime Minister Narendra Modi has proposed legislation to prohibit social media access for children under 16, framing the move as a response to digital addiction and the exploitation of Indian user data by foreign tech giants, amid a growing global regulatory push.

Jan 31, 2026

World

Surviving the Siege: A Doctor's Flight from Darfur's Fallen Stronghold

In a rare firsthand account, Dr. Mohamed Ibrahim details his three-day escape from el-Fasher as paramilitary forces overran the city. His testimony paints a harrowing picture of urban warfare, civilian slaughter, and the systematic collapse of Sudan's last army bastion in Darfur.

Jan 31, 2026

World

Through Hell in Darfur: A Doctor's Harrowing Escape from Besieged el-Fasher Reveals Scale of Atrocities

Exclusive testimony from Dr. Mohamed Ibrahim, who fled the last hospital in Sudan's strategic el-Fasher, details a three-day ordeal of hiding from paramilitary forces, witnessing mass casualties, and surviving a kidnapping and ransom demand—shedding light on a siege the U.N. calls a 'massive crime scene.'

Jan 31, 2026

Business

Sarepta's Gene Therapy Shows Sustained Slowing of DMD Progression in Landmark Three-Year Data

New long-term results from the pivotal EMBARK trial indicate ELEVIDYS, Sarepta's gene therapy, continues to alter the disease trajectory for boys with Duchenne muscular dystrophy, with no new safety concerns emerging over three years.

Jan 31, 2026

Business

Musk's Weekend Focus: Tesla's Future Hinges on AI Chip Breakthrough, Not Cars

In a revealing moment during Tesla's earnings call, Elon Musk disclosed that his Saturdays are dedicated to the company's next-generation AI5 chip project, signaling a fundamental strategic shift from automaker to vertically integrated AI hardware powerhouse.

Jan 31, 2026